{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:22:34Z","timestamp":1789593754566,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.blre.2025.101340","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T22:46:41Z","timestamp":1760654801000},"page":"101340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Artificial intelligence in myeloid malignancies: Clinical applications of machine learning in myelodysplastic syndromes and acute myeloid Leukemia"],"prefix":"10.1016","volume":"74","author":[{"given":"Jowan","family":"Al-Nusair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Lanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arda","family":"Durmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo Giovanni Della","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer M.","family":"Zeidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Kewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.blre.2025.101340_bb0005","article-title":"Artificial intelligence: a powerful paradigm for scientific research","volume":"2","author":"Xu","year":"2021","journal-title":"Innovation (Camb)"},{"issue":"15","key":"10.1016\/j.blre.2025.101340_bb0010","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3390\/diagnostics13152582","article-title":"What is machine learning, artificial neural networks and deep learning? Examples of practical applications in medicine","volume":"13","author":"Kufel","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41591-018-0307-0","article-title":"The practical implementation of artificial intelligence technologies in medicine","volume":"25","author":"He","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2025.101340_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.101019","article-title":"Artificial intelligence in hematological diagnostics: game changer or gadget?","volume":"58","author":"Walter","year":"2023","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13054-024-05005-y","article-title":"Should AI models be explainable to clinicians?","volume":"28","author":"Abgrall","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.blre.2025.101340_bb0030","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7702","article-title":"The impact of artificial intelligence in medicine on the future role of the physician","volume":"7","author":"Ahuja","year":"2019","journal-title":"PeerJ"},{"issue":"8","key":"10.1016\/j.blre.2025.101340_bb0035","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Garcia-Manero","year":"2023","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.blre.2025.101340_bb0040","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2025.101340_bb0045","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0050","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/hematology.2023000456","article-title":"Novel therapies upon failure of HMA plus venetoclax","volume":"2023","author":"Chan","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.blre.2025.101340_bb0055","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1016\/S2352-3026(25)00137-1","article-title":"Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time","volume":"12","author":"Kirschner","year":"2025","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2025.101340_bb0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/EDBK_239083","article-title":"CHIP, CCUS, and other acronyms: definition, implications, and impact on practice","volume":"39","author":"DeZern","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"12","key":"10.1016\/j.blre.2025.101340_bb0065","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2025.101340_bb0070","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ajh.27625","article-title":"Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management","volume":"100","author":"Shimony","year":"2025","journal-title":"Am J Hematol"},{"issue":"Suppl. 2","key":"10.1016\/j.blre.2025.101340_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajh.27482","article-title":"Measurable residual disease monitoring in AML: prospects for therapeutic decision-making and new drug development","volume":"100","author":"Short","year":"2025","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.blre.2025.101340_bb0080","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_438662","article-title":"Advancements and challenges in the treatment of AML","volume":"44","author":"Abaza","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"7","key":"10.1016\/j.blre.2025.101340_bb0085","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.blre.2025.101340_bb0090","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.blre.2025.101340_bb0095","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/bloodadvances.2023010173","article-title":"Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting","volume":"7","author":"Attardi","year":"2023","journal-title":"Blood Adv"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2025.101340_bb0100","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1182\/blood-2024-207770","article-title":"Clinical and molecular insights into the classification dilemma: are MDS\/AML cases distinct from secondary AML?","volume":"144","author":"Kewan","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101340_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101102","article-title":"Artificial intelligence in sickle disease","volume":"61","author":"Elsabagh","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2025.101340_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101134","article-title":"Revolutionizing chronic lymphocytic leukemia diagnosis: a deep dive into the diverse applications of machine learning","volume":"62","author":"Elhadary","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2025.101340_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2021.105999","article-title":"A deep learning model (ALNet) for the diagnosis of acute leukaemia lineage using peripheral blood cell images","volume":"202","author":"Bold\u00fa","year":"2021","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.blre.2025.101340_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101144","article-title":"From microscope to micropixels: a rapid review of artificial intelligence for the peripheral blood film","volume":"64","author":"Fan","year":"2024","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.blre.2025.101340_bb0125","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3324\/haematol.2022.280406","article-title":"Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learning","volume":"107","author":"Cheli","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ijlh.14180","article-title":"A comparative evaluation of three consecutive artificial intelligence algorithms released by Techcyte for identification of blasts and white blood cells in abnormal peripheral blood films","volume":"46","author":"Lincz","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2025.101340_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2022.107314","article-title":"Automatic generation of artificial images of leukocytes and leukemic cells using generative adversarial networks (syntheticcellgan)","volume":"229","author":"Barrera","year":"2023","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/bloodadvances.2023011076","article-title":"Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears","volume":"8","author":"Kockwelp","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100373","article-title":"Automated deep learning-based diagnosis and molecular characterization of acute myeloid leukemia using flow cytometry","volume":"37","author":"Lewis","year":"2024","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.blre.2025.101340_bb0150","first-page":"2435","article-title":"Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry","volume":"108","author":"Clichet","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101340_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106639","article-title":"A machine learning approach to predicting risk of myelodysplastic syndrome","volume":"109","author":"Radhachandran","year":"2021","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.blre.2025.101340_bb0160","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/cyto.b.21975","article-title":"Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics","volume":"100","author":"Rosenberg","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"10.1016\/j.blre.2025.101340_bb0165","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1158\/2643-3230.BCD-20-0162","article-title":"Machine learning of bone marrow histopathology identifies genetic and clinical determinants in patients with MDS","volume":"2","author":"Br\u00fcck","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"7","key":"10.1016\/j.blre.2025.101340_bb0170","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.blre.2025.101340_bb0175","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/blood.2023023727","article-title":"Molecular taxonomy of myelodysplastic syndromes and its clinical implications","volume":"144","author":"Bernard","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0180","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/s41467-023-38515-4","article-title":"Molecular patterns identify distinct subclasses of myeloid neoplasia","volume":"14","author":"Kewan","year":"2023","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.blre.2025.101340_bb0185","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.20.01659","article-title":"Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes","volume":"39","author":"Bersanelli","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2025.101340_bb0190","article-title":"MOSAIC: an artificial intelligence-based framework for multimodal analysis, classification, and personalized prognostic assessment in rare cancers","volume":"8","author":"D\u2019Amico","year":"2024","journal-title":"JCO Clin Cancer Inform"},{"issue":"20","key":"10.1016\/j.blre.2025.101340_bb0195","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1182\/blood.2020005488","article-title":"Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes","volume":"136","author":"Nagata","year":"2020","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.blre.2025.101340_bb0200","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood.2020010603","article-title":"Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia","volume":"138","author":"Awada","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2025.101340_bb0205","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12911-023-02408-9","article-title":"Multiple machine-learning tools identifying prognostic biomarkers for acute myeloid leukemia","volume":"24","author":"Cheng","year":"2024","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"10.1016\/j.blre.2025.101340_bb0215","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2021.280027","article-title":"Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning","volume":"108","author":"Eckardt","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101340_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107437","article-title":"Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: a DATAML registry study","volume":"136","author":"Didi","year":"2024","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.blre.2025.101340_bb0225","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000961","article-title":"Machine learning improves risk stratification in myelodysplastic neoplasms: an analysis of the Spanish Group of Myelodysplastic Syndromes","volume":"7","author":"Mosquera Orgueira","year":"2023","journal-title":"Hemasphere"},{"issue":"4","key":"10.1016\/j.blre.2025.101340_bb0230","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/bjh.19341","article-title":"Validation of the artificial intelligence prognostic scoring system for myelodysplastic syndromes in chronic myelomonocytic leukaemia: a novel approach for improved risk stratification","volume":"204","author":"Mosquera Orgueira","year":"2024","journal-title":"Br J Haematol"},{"issue":"33","key":"10.1016\/j.blre.2025.101340_bb0235","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.20.02810","article-title":"Personalized prediction model to risk stratify patients with myelodysplastic syndromes","volume":"39","author":"Nazha","year":"2021","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.blre.2025.101340_bb0240","first-page":"2047","article-title":"Consensus proposal for revised international working group 2023 response criteria for higher-risk myelodysplastic syndromes","volume":"141","author":"Zeidan","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101340_bb0245","article-title":"Genomic biomarkers to predict resistance to hypomethylating agents in patients with myelodysplastic syndromes using artificial intelligence","volume":"3","author":"Nazha","year":"2019","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0250","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41698-023-00374-z","article-title":"Prediction model for drug response of acute myeloid leukemia patients","volume":"7","author":"Trac","year":"2023","journal-title":"NPJ Precis Oncol"},{"issue":"10","key":"10.1016\/j.blre.2025.101340_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104931","article-title":"A machine learning model of response to hypomethylating agents in myelodysplastic syndromes","volume":"25","author":"Radakovich","year":"2022","journal-title":"iScience"},{"issue":"24","key":"10.1016\/j.blre.2025.101340_bb0260","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.23.02175","article-title":"Clinical and genomic-based decision support system to define the optimal timing of allogeneic hematopoietic stem-cell transplantation in patients with myelodysplastic syndromes","volume":"42","author":"Tentori","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2025.101340_bb0265","article-title":"Machine learning-based exploratory clinical decision support for newly diagnosed patients with acute myeloid leukemia treated with 7+3 type chemotherapy or venetoclax\/azacitidine","volume":"6","author":"Islam","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.blre.2025.101340_bb0270","article-title":"Predicting in-hospital mortality after acute myeloid leukemia therapy: through supervised machine learning algorithms","volume":"6","author":"Siddiqui","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.blre.2025.101340_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659595","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia: who, when, and how?","volume":"12","author":"Loke","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.blre.2025.101340_bb0280","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1159\/000547767","article-title":"Artificial intelligence in hematopoietic stem cell transplantation care and complication management","volume":"148","author":"Turki","year":"2025","journal-title":"Acta Haematol"},{"issue":"28","key":"10.1016\/j.blre.2025.101340_bb0285","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2014.59.1339","article-title":"Prediction of allogeneic hematopoietic stem-cell transplantation mortality 100 days after transplantation using a machine learning algorithm: a European Group for Blood and Marrow Transplantation Acute Leukemia Working Party retrospective data mining study","volume":"33","author":"Shouval","year":"2015","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.blre.2025.101340_bb0290","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70672","article-title":"Survival prediction in allogeneic haematopoietic stem cell transplant recipients using pre- and post-transplant factors and computational intelligence","volume":"29","author":"Asteris","year":"2025","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.blre.2025.101340_bb0295","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jtim-2025-0028","article-title":"Artificial intelligence-based predictive model for relapse in acute myeloid leukemia patients following haploidentical hematopoietic cell transplantation","volume":"13","author":"Fan","year":"2025","journal-title":"J Transl Int Med"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: a scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"NPJ Digit Med"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2025.101340_bb0305","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood-2024-209634","article-title":"A comprehensive, artificial intelligence, digital twin platform based on multimodal real-world data integration for personalized medicine in hematology","volume":"144","author":"D\u2019Amico","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0310","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13073-019-0701-3","article-title":"Digital twins to personalize medicine","volume":"12","author":"Bj\u00f6rnsson","year":"2019","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0315","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41746-024-01076-x","article-title":"Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence","volume":"7","author":"Eckardt","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.blre.2025.101340_bb0320","article-title":"Synthetic data generation by artificial intelligence to accelerate research and precision medicine in hematology","volume":"7","author":"D\u2019Amico","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2025.101340_bb0325","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1182\/blood-2022-164559","volume":"140","author":"Lanino","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101340_bb0330","doi-asserted-by":"crossref","first-page":"1563991","DOI":"10.3389\/fdgth.2025.1563991","article-title":"Synthetic data generation: a privacy-preserving approach to accelerate rare disease research","volume":"7","author":"Mendes","year":"2025","journal-title":"Front Digit Health"},{"key":"10.1016\/j.blre.2025.101340_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100914","article-title":"The future of research in hematology: integration of conventional studies with real-world data and artificial intelligence","volume":"54","author":"Passamonti","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2025.101340_bb0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41746-020-00323-1","article-title":"The future of digital health with federated learning","volume":"3","author":"Rieke","year":"2020","journal-title":"NPJ Digit Med"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0345","doi-asserted-by":"crossref","first-page":"12598","DOI":"10.1038\/s41598-020-69250-1","article-title":"Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data","volume":"10","author":"Sheller","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.blre.2025.101340_bb0350","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1002\/cam4.3935","article-title":"Artificial intelligence in oncology: path to implementation","volume":"10","author":"Chua","year":"2021","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.blre.2025.101340_bb0355","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41591-021-01517-0","article-title":"A quality assessment tool for artificial intelligence-centered diagnostic test accuracy studies: QUADAS-AI","volume":"27","author":"Sounderajah","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2025.101340_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2025.101340_bb0365","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.blre.2025.101340_bb0370","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1109\/OJEMB.2024.3485534","article-title":"Advancements in clinical evaluation and regulatory frameworks for AI-driven software as a medical device (SaMD)","volume":"6","author":"Yang","year":"2024","journal-title":"IEEE Open J Eng Med Biol"},{"issue":"9","key":"10.1016\/j.blre.2025.101340_bb0375","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-020-1037-7","article-title":"Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension","volume":"26","author":"Cruz Rivera","year":"2020","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.blre.2025.101340_bb0380","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1016\/S2589-7500(20)30218-1","article-title":"Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension","volume":"2","author":"Liu","year":"2020","journal-title":"Lancet Digit Health"},{"issue":"12","key":"10.1016\/j.blre.2025.101340_bb0385","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2023.10.001","article-title":"ESMO guidance for reporting oncology real-world evidence (GROW)","volume":"34","author":"Castelo-Branco","year":"2023","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.blre.2025.101340_bb0390","doi-asserted-by":"crossref","first-page":"AIp2401106","DOI":"10.1056\/AIp2401106","article-title":"Development, evaluation, and assessment of large language models (DEAL) checklist: a technical report","volume":"2","author":"Tripathi","year":"2025","journal-title":"NEJM AI"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0395","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41746-025-01722-y","article-title":"Systematic review of cost effectiveness and budget impact of artificial intelligence in healthcare","volume":"8","author":"El Arab","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.blre.2025.101340_bb0400","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1613\/jair.1.15348","article-title":"Human-in-the-loop reinforcement learning: a survey and position on requirements, challenges, and opportunities","volume":"79","author":"Retzlaff","year":"2024","journal-title":"J Artif Intell Res"},{"issue":"1","key":"10.1016\/j.blre.2025.101340_bb0405","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2024-101139","article-title":"Large language models for data extraction from unstructured and semi-structured electronic health records: a multiple model performance evaluation","volume":"32","author":"Ntinopoulos","year":"2025","journal-title":"BMJ Health Care Inform"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X25000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X25000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T17:34:45Z","timestamp":1766079285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X25000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":81,"alternative-id":["S0268960X25000852"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2025.101340","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence in myeloid malignancies: Clinical applications of machine learning in myelodysplastic syndromes and acute myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2025.101340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101340"}}